Categories Earnings, Health Care
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.
- Revenue was $1.03 billion in the September quarter, an increase of 3.8% from $989.2 million last year
- Organic revenue rose 4.1%, driven primarily by the Discovery and Safety Assessment and Research Models and Services businesses
- Third-quarter net income decreased 9.4% annually to $87.4 million; earnings per share were $1.69, down 10.1%
- Adjusted net income increased to $140.5 million or $2.72 per share from $134.7 million or $2.63 per share in Q3 2022
- The management expects revenues to grow between 2.5% and 3.5% in fiscal 2023
- Organic revenue is estimated to increase in the range of 5.5% to $6.5%
- The company is looking for full-year earnings in the range of $7.30 per share to $7.50 per share
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Deere & Company (DE) performed in Q2 2024
Deere & Company (NYSE: DE) reported second quarter 2024 earnings results today. Total net sales and revenues decreased 12% year-over-year to $15.2 billion. Net income was $2.37 billion, or $8.53
WMT Earnings: Key quarterly highlights from Walmart’s Q1 2025 financial results
Walmart Inc. (NYSE: WMT) reported its first quarter 2025 earnings results today. Consolidated revenue increased 6% year-over-year to $161.5 billion. Revenue growth on a constant currency basis was 5.8%. Consolidated
Home Depot (HD): A look at how the home improvement retailer fared in Q1 2024
Shares of Home Depot (NYSE: HD) rose over 2% on Wednesday. The stock has gained 19% over the past 12 months. The company delivered mixed results for the first quarter
